402 - 625, avenue du Président-Kennedy
Montréal, Québec
Canada
H3A 3S5
Sigle : CRS
Adresse Internet : http://www.cancer-research-society.ca

  Programme(s) de recherche actif(s)

  Projet(s) actif(s)
    Amino acid neurotransmitter reprogramming of the tumour microenvironment and metabolism in glioblastoma
    Assessment of a novel TLR7/8 agonist in lung cancer
    Circulating basophils and eosinophils as novel biomarkers for non-muscle invasive cancer bladder cancer
    Identifying epithelial-to-mesenchymal transition effectors in aggressive basal cell carcinoma
    Identifying epithelial-to-mesenchymal transition effectors in aggressive basal cell carcinoma
    Impact of 2-hydroxyglutarate-induced astrocytes reactivity in low-grade glioma progression and recurrence
    Repurposing bicalutamide to improve the response to immune checkpoint inhibition for treatment of advanced urothelial carcinoma
    Targeting the prostate cancer metabolic program established upon loss of the KLF5 gene
    Targeting the sonic hedgehog medulloblastoma metabolic program for therapeutic purposes
    The effect of cannabinoid receptors on breast cancer survival
    UGT2B28 IS A PROGNOSTIC AND PREDICTIVE BIOMARKER IN PROSTATE CANCER
    Unveiling the roles of Poly(ADP)ribose Glycohydrolase (PARG) in DNA repair and cancer